ZA716615B - Arylpyrimidines-inhibitors of platelet aggregation and bronchodilators - Google Patents

Arylpyrimidines-inhibitors of platelet aggregation and bronchodilators

Info

Publication number
ZA716615B
ZA716615B ZA716615A ZA716615A ZA716615B ZA 716615 B ZA716615 B ZA 716615B ZA 716615 A ZA716615 A ZA 716615A ZA 716615 A ZA716615 A ZA 716615A ZA 716615 B ZA716615 B ZA 716615B
Authority
ZA
South Africa
Prior art keywords
arylpyrimidines
bronchodilators
inhibitors
platelet aggregation
platelet
Prior art date
Application number
ZA716615A
Other languages
English (en)
Inventor
Angelis G De
H Hess
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA716615B publication Critical patent/ZA716615B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30—Halogen atoms or nitro radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56—One oxygen atom and one sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D333/70—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ZA716615A 1970-10-05 1971-10-04 Arylpyrimidines-inhibitors of platelet aggregation and bronchodilators ZA716615B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7821670A 1970-10-05 1970-10-05

Publications (1)

Publication Number Publication Date
ZA716615B true ZA716615B (en) 1972-06-28

Family

ID=22142671

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA716615A ZA716615B (en) 1970-10-05 1971-10-04 Arylpyrimidines-inhibitors of platelet aggregation and bronchodilators

Country Status (16)

Country Link
US (1) US3707560A (fi)
JP (2) JPS5648511B1 (fi)
AT (4) AT315856B (fi)
AU (1) AU465734B2 (fi)
BE (1) BE773484A (fi)
CA (1) CA988519A (fi)
CH (4) CH554346A (fi)
DE (2) DE2165962C2 (fi)
DK (1) DK131858C (fi)
ES (4) ES395676A1 (fi)
FI (1) FI55502C (fi)
FR (1) FR2110227B1 (fi)
GB (2) GB1373536A (fi)
NL (1) NL168511C (fi)
SE (2) SE385885B (fi)
ZA (1) ZA716615B (fi)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3859288A (en) * 1970-10-05 1975-01-07 Pfizer Arylpyrimidines - inhibitors of platelet aggregation and bronchodilators
US3895112A (en) * 1970-10-05 1975-07-15 Pfizer Arylpyrimidines in the relaxation of smooth muscle
US3908012A (en) * 1970-10-05 1975-09-23 Pfizer Arylpyrimidines-inhibitors of platelet aggregation and bronchodilators
US3835132A (en) * 1972-02-01 1974-09-10 Shell Oil Co Morpholino-piperazinyl pyrimidines
US3950525A (en) * 1973-06-19 1976-04-13 Pfizer Inc. Relaxation of smooth muscle in a mammal
DE2343419A1 (de) * 1973-08-29 1975-03-13 Gruenenthal Chemie Verfahren zur herstellung von pyrimidinderivaten
US4725600A (en) * 1984-07-13 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Pyrimidine compounds having activity as a cardiotonic anti-hypertensive cerebrovascular vasodilator and anti-platelet aggregation agent
JPH0625157B2 (ja) * 1988-01-29 1994-04-06 宇部興産株式会社 ４―ヒドロキシピリミジン類の製造方法
US4935516A (en) * 1988-01-29 1990-06-19 Ube Industries, Ltd. Process for preparing 4-hydroxypyrimidine
DE3825647A1 (de) * 1988-07-28 1990-02-01 Geyer Gmbh & Co Christian Vorrichtung zur befestigung eines elektrischen schaltgeraetes
DE3905364A1 (de) * 1989-02-22 1990-08-23 Hoechst Ag Substituierte pyrimidin-derivate, verfahren zu ihrer herstellung und ihre verwendung als tool
DE60005355T2 (de) * 1999-07-15 2004-07-01 Pharmacopeia, Inc. Bradikinin b1 rezeptor antagonisten
WO2003077656A1 (en) * 2002-03-15 2003-09-25 Ciba Specialty Chemicals Holding Inc. 4-aminopyrimidines and their use for the antimicrobial treatment of surfaces
CA2486376A1 (en) * 2002-05-22 2003-12-04 Amgen Inc. Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
JP2006521345A (ja) * 2003-03-28 2006-09-21 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー ニコチン性アセチルコリン受容体の正のアロステリック調節剤
US20060235036A1 (en) * 2005-04-15 2006-10-19 Doherty Elizabeth M Vanilloid receptor ligands and their use in treatments
JP2009164373A (ja) * 2008-01-08 2009-07-23 Toshiba Corp 半導体装置
EP2528441A4 (en) * 2010-01-25 2013-07-10 Chdi Foundation Inc CERTAIN KYNURENIN-3-MONOOXYGENASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF
SG2014011654A (en) 2011-08-30 2014-08-28 Chdi Foundation Inc Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
AU2012302144B2 (en) 2011-08-30 2017-06-15 Chdi Foundation, Inc. Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
CA2955379C (en) 2014-07-17 2022-12-13 Chdi Foundation, Inc. Methods and compositions for treating hiv-related disorders

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3047462A (en) * 1959-03-06 1962-07-31 Lab Jacques Logeais Soc D Expl Quinazolone anti-inflammatory composition

Also Published As

Publication number Publication date
SE385885B (sv) 1976-07-26
DE2149249A1 (de) 1972-04-13
BE773484A (fr) 1972-04-05
ES420211A1 (es) 1976-03-16
NL7113670A (fi) 1972-04-07
AU465734B2 (en) 1975-10-09
ES420209A1 (es) 1976-06-01
JPS578107B2 (fi) 1982-02-15
AT317229B (de) 1974-08-26
CA988519A (en) 1976-05-04
CH554346A (fr) 1974-09-30
AU3425971A (en) 1973-04-12
GB1373535A (en) 1974-11-13
FR2110227B1 (fi) 1975-02-07
JPS5636468A (en) 1981-04-09
AT315856B (de) 1974-05-15
SE390304B (sv) 1976-12-13
NL168511B (nl) 1981-11-16
DK131858B (da) 1975-09-15
ES395676A1 (es) 1974-10-16
CH554875A (fr) 1974-10-15
DE2165962A1 (de) 1972-08-31
DE2165962C2 (de) 1982-05-13
CH542218A (fr) 1973-11-15
DE2149249B2 (de) 1974-11-07
AT314540B (de) 1974-04-10
FI55502B (fi) 1979-04-30
JPS5648511B1 (fi) 1981-11-16
CH554876A (fr) 1974-10-15
NL168511C (nl) 1982-04-16
US3707560A (en) 1972-12-26
GB1373536A (en) 1974-11-13
AT316563B (de) 1974-06-15
FR2110227A1 (fi) 1972-06-02
DE2149249C3 (de) 1975-07-03
ES420210A1 (es) 1976-06-01
DK131858C (da) 1976-02-16
SE7410488L (fi) 1974-08-16
FI55502C (fi) 1979-08-10

Similar Documents

Publication Publication Date Title
ZA716615B (en) Arylpyrimidines-inhibitors of platelet aggregation and bronchodilators
GB1367959A (en) Absorbent products and methods of making the same
ZA71682B (en) New phenoxy-hydroxypropylamines and their preparation
JPS5555164A (en) Manufacture of nn*1*1*11trisubstituted** methylazole
JPS57131760A (en) Manufacture of aminophenylcycloamidine and salt of same
JPS5444663A (en) Manufacture of aminophenyllcycloamidine and its salts
JPS5677256A (en) Manufacture of nnalkyllnnchlorothiocarbamoylchloride
JPS5762294A (en) Manufacture of 5'-o-acyl-ara-cytidines
JPS5547654A (en) Manufacture of 55aroyll*betaahydroxyethyl** 11lower alkylpyrrole
HK15678A (en) Preparation of 5-fluoropyrimidines and novel intermediate therefrom
IL40123A0 (en) Imidazolines and their preparation
IL39221A0 (en) The preparation of 5-benzyl-pyrimidines and certain novel 5-benzyl-pyrimidines
HK79079A (en) Complexes of alpha-6-deoxy-5-hydroxytetracycline and their preparation
IE35221B1 (en) Improvements in the manufacture of spacer-expanders
IL37762A0 (en) New penicillins and their preparation
ZA718466B (en) Improvements in or relating to compounds of the pregnome and adrostane series
JPS5559174A (en) Manufacture of 33substituted methylquinoxalinee22carboxyamidoo1*44dioxide
IL38383A0 (en) Manufacture of 6-methylene-tetracycline
IL37971A (en) 2-amino-4-thiocyanatobenzothiazoles and their preparation
IL36828A0 (en) Preparation of alkylene-dioxyheptanones
IL36700A0 (en) The manufacture of dea-9beta-steroids and certain new such compounds
IL35306A0 (en) Manufacture of muconodinitrile
IL38183A0 (en) Herbicidally-active substituted phenylthiocarbamates and their manufacture and use
IL37008A (en) Cyclophosphates and their preparation
IL37932A (en) 2-amino-4-thiocyanatobenzothiazoles and their preparation